A notable trend toward higher starting doses is observed in autoimmune disease trials, likely reflecting the hypothesis that a “hard reset” of the immune system is required for these conditions [ 33 ].
1
—
—
A notable trend toward higher starting doses is observed in autoimmune disease trials, likely reflecting the hypothesis that a “hard reset” of the immune system is required for these conditions [ 33 ].